TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Flow Nasal Cannula Versus Nasal Intermittent Mandatory Ventilation for Respiratory Distress Syndrome: a Randomized, Controlled, Prospective Study
Brief Summary: The investigators hypothesize that while the extremely low birthweight (ELBW) infants (\<1000 g) may need NIMV for the treatment of RDS, larger infants or the smaller ones post extubation may enjoy the comfort benefits associated with HFNC while getting coparable respiratory support to NIMV.


Options:
A: Arm Label: NSIPPV group; Type: ACTIVE_COMPARATOR; Interventions: Device: NSIPPV | Arm Label: BiPAP group; Type: ACTIVE_COMPARATOR; Interventions: Device: BiPAP | Intervention Type: DEVICE; Name: NSIPPV; Assigned to Arm(s): NSIPPV group | Intervention Type: DEVICE; Name: BiPAP; Assigned to Arm(s): BiPAP group
B: Arm Label: NIPPV; Type: ACTIVE_COMPARATOR; Interventions: Device: NIPPV | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: NIPPV | Intervention Type: DEVICE; Name: NIPPV; Assigned to Arm(s): Control, NIPPV | Intervention Type: DEVICE; Name: NIPPV; Assigned to Arm(s): Control, NIPPV | Intervention Type: DEVICE; Name: NIPPV; Assigned to Arm(s): Control, NIPPV
C: Arm Label: NCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: nasal intermittent positive pressure ventilation | Arm Label: NIPPV; Type: EXPERIMENTAL; Interventions: Device: nasal intermittent positive pressure ventilation | Intervention Type: DEVICE; Name: nasal intermittent positive pressure ventilation; Assigned to Arm(s): NCPAP, NIPPV
D: Arm Label: NIMV- nasal respiratory support; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Arm Label: HFNC- nasal respiratory support with HFNC; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Intervention Type: DEVICE; Name: NIMV with SLE ventilator vs HFNC via Vapotherm; Assigned to Arm(s): HFNC- nasal respiratory support with HFNC, NIMV- nasal respiratory support

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Flow Nasal Cannula Versus Nasal Intermittent Mandatory Ventilation for Respiratory Distress Syndrome: a Randomized, Controlled, Prospective Study
Brief Summary: The investigators hypothesize that while the extremely low birthweight (ELBW) infants (\<1000 g) may need NIMV for the treatment of RDS, larger infants or the smaller ones post extubation may enjoy the comfort benefits associated with HFNC while getting coparable respiratory support to NIMV.


Options:
A: Arm Label: NIMV- nasal respiratory support; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Arm Label: HFNC- nasal respiratory support with HFNC; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Intervention Type: DEVICE; Name: NIMV with SLE ventilator vs HFNC via Vapotherm; Assigned to Arm(s): HFNC- nasal respiratory support with HFNC, NIMV- nasal respiratory support
B: Arm Label: CPAP group; Type: EXPERIMENTAL; Interventions: Device: CPAP | Arm Label: Nasal Cannula Group; Type: EXPERIMENTAL; Interventions: Device: Nasal Cannula | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): CPAP group | Intervention Type: DEVICE; Name: Nasal Cannula; Assigned to Arm(s): Nasal Cannula Group
C: Arm Label: HFNC; Type: EXPERIMENTAL; Interventions: Device: Respiratory support HFNC, Device: Respiratory support NCPAP | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Respiratory support HFNC, Device: Respiratory support NCPAP | Intervention Type: DEVICE; Name: Respiratory support HFNC; Assigned to Arm(s): HFNC, nCPAP | Intervention Type: DEVICE; Name: Respiratory support NCPAP; Assigned to Arm(s): HFNC, nCPAP
D: Arm Label: HHFNC; Type: ACTIVE_COMPARATOR; Interventions: Other: Nasal CPAP, Other: Humidified High Flow Nasal Cannula (HHFNC) | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Other: Nasal CPAP, Other: Humidified High Flow Nasal Cannula (HHFNC) | Intervention Type: OTHER; Name: Nasal CPAP; Assigned to Arm(s): HHFNC, nCPAP | Intervention Type: OTHER; Name: Humidified High Flow Nasal Cannula (HHFNC); Assigned to Arm(s): HHFNC, nCPAP

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Flow Nasal Cannula Versus Nasal Intermittent Mandatory Ventilation for Respiratory Distress Syndrome: a Randomized, Controlled, Prospective Study
Brief Summary: The investigators hypothesize that while the extremely low birthweight (ELBW) infants (\<1000 g) may need NIMV for the treatment of RDS, larger infants or the smaller ones post extubation may enjoy the comfort benefits associated with HFNC while getting coparable respiratory support to NIMV.


Options:
A: Arm Label: HFNC; Type: EXPERIMENTAL; Interventions: Device: Respiratory support HFNC, Device: Respiratory support NCPAP | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Respiratory support HFNC, Device: Respiratory support NCPAP | Intervention Type: DEVICE; Name: Respiratory support HFNC; Assigned to Arm(s): HFNC, nCPAP | Intervention Type: DEVICE; Name: Respiratory support NCPAP; Assigned to Arm(s): HFNC, nCPAP
B: Arm Label: HHFNC; Type: ACTIVE_COMPARATOR; Interventions: Other: Nasal CPAP, Other: Humidified High Flow Nasal Cannula (HHFNC) | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Other: Nasal CPAP, Other: Humidified High Flow Nasal Cannula (HHFNC) | Intervention Type: OTHER; Name: Nasal CPAP; Assigned to Arm(s): HHFNC, nCPAP | Intervention Type: OTHER; Name: Humidified High Flow Nasal Cannula (HHFNC); Assigned to Arm(s): HHFNC, nCPAP
C: Arm Label: PS Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: PS Group | Arm Label: NCPAP Group; Type: EXPERIMENTAL; Interventions: Device: NCPAP Group | Arm Label: ISX Group; Type: EXPERIMENTAL; Interventions: Drug: ISX Group | Intervention Type: DRUG; Name: PS Group; Assigned to Arm(s): PS Group | Intervention Type: DEVICE; Name: NCPAP Group; Assigned to Arm(s): NCPAP Group | Intervention Type: DRUG; Name: ISX Group; Assigned to Arm(s): ISX Group
D: Arm Label: NIMV- nasal respiratory support; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Arm Label: HFNC- nasal respiratory support with HFNC; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Intervention Type: DEVICE; Name: NIMV with SLE ventilator vs HFNC via Vapotherm; Assigned to Arm(s): HFNC- nasal respiratory support with HFNC, NIMV- nasal respiratory support

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guidance for Radial Arterial Blood Sampling
Brief Summary: The investigators aim to determine if ultrasound guidance results in improved technique when drawing blood via a radial artery puncture.


Options:
A: Arm Label: Arterial catheter; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Arm Label: Placement; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Intervention Type: PROCEDURE; Name: Laying a radial or femoral arterial catheter; Assigned to Arm(s): Arterial catheter, Placement
B: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group
C: Arm Label: With ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: Artery puncture with ultrasound guidance | Arm Label: Without ultrasound guidance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Artery puncture without ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture with ultrasound guidance; Assigned to Arm(s): With ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture without ultrasound guidance; Assigned to Arm(s): Without ultrasound guidance
D: Arm Label: Distal radial artery access; Type: EXPERIMENTAL; Interventions: Procedure: Distal radial artery access | Arm Label: Proximal radial artery access; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Proximal radial artery surgery | Intervention Type: PROCEDURE; Name: Distal radial artery access; Assigned to Arm(s): Distal radial artery access | Intervention Type: PROCEDURE; Name: Proximal radial artery surgery; Assigned to Arm(s): Proximal radial artery access

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guidance for Radial Arterial Blood Sampling
Brief Summary: The investigators aim to determine if ultrasound guidance results in improved technique when drawing blood via a radial artery puncture.


Options:
A: Arm Label: Dynamic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dynamic | Arm Label: Regular-triangle; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Regular-triangle | Intervention Type: BEHAVIORAL; Name: dynamic; Assigned to Arm(s): Dynamic | Intervention Type: BEHAVIORAL; Name: Regular-triangle; Assigned to Arm(s): Regular-triangle
B: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group
C: Arm Label: With ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: Artery puncture with ultrasound guidance | Arm Label: Without ultrasound guidance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Artery puncture without ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture with ultrasound guidance; Assigned to Arm(s): With ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture without ultrasound guidance; Assigned to Arm(s): Without ultrasound guidance
D: Arm Label: Infant; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Arm Label: Preschool child; Type: EXPERIMENTAL; Interventions: Other: Long-axis/in-plane US-guided arterial catheterization, Other: Short-axis/out-of-plane US-guided arterial catheterization | Intervention Type: OTHER; Name: Long-axis/in-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child | Intervention Type: OTHER; Name: Short-axis/out-of-plane US-guided arterial catheterization; Assigned to Arm(s): Infant, Preschool child

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ultrasound Guidance for Radial Arterial Blood Sampling
Brief Summary: The investigators aim to determine if ultrasound guidance results in improved technique when drawing blood via a radial artery puncture.


Options:
A: Arm Label: Ultrasound radial artery catheter; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided radial artery catheterization. | Arm Label: Palpation based artery catheterization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blind insertion of radial artery catheterization | Intervention Type: PROCEDURE; Name: Ultrasound guided radial artery catheterization.; Assigned to Arm(s): Ultrasound radial artery catheter | Intervention Type: PROCEDURE; Name: Blind insertion of radial artery catheterization; Assigned to Arm(s): Palpation based artery catheterization
B: Arm Label: Ultrasound guided arterial puncture; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound guided arterial puncture | Arm Label: Conventional arterial puncture technique; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional arterial puncture technique | Intervention Type: PROCEDURE; Name: Ultrasound guided arterial puncture; Assigned to Arm(s): Ultrasound guided arterial puncture | Intervention Type: PROCEDURE; Name: Conventional arterial puncture technique; Assigned to Arm(s): Conventional arterial puncture technique
C: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG
D: Arm Label: With ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: Artery puncture with ultrasound guidance | Arm Label: Without ultrasound guidance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Artery puncture without ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture with ultrasound guidance; Assigned to Arm(s): With ultrasound guidance | Intervention Type: PROCEDURE; Name: Artery puncture without ultrasound guidance; Assigned to Arm(s): Without ultrasound guidance

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bio-equivalency Study of the Effects of Vitamin D2 and Vitamin D3 Supplements on 25-hydroxyvitamin D Levels in Exclusively Breast Fed Canadian Infants
Brief Summary: There are two different types of vitamin D - vitamin D3 (animal source) and vitamin D2 (plant source). Almost all the usual vitamin D preparations for infants available in Canadian pharmacies contain vitamin D3 which may not be suitable for families who avoid animal products for social or religious reasons. The purpose of this study is to learn more about the two forms of vitamin D and if blood levels of vitamin D are similar in infants after taking them. Forty-eight breastfed infants will be randomly assigned to 400 IU of either vitamin D2 or D3 supplement for 3 months starting at 1 month of age. The difference in blood vitamin D levels, after 3 months of supplementation, between the two groups will help determine if the two supplements are equal.


Options:
A: Arm Label: Single, high dose oral vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3, Dietary Supplement: Standard Vitamin D3 Supplementation | Arm Label: Standard Vitamin D Supplementation; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard Vitamin D3 Supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Single, high dose oral vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard Vitamin D3 Supplementation; Assigned to Arm(s): Single, high dose oral vitamin D3, Standard Vitamin D Supplementation
B: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Arm Label: Placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3 (cholecalciferol); Assigned to Arm(s): Vitamin D3
C: Arm Label: Atopic dermatitis patients: Active; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral vitamin D | Arm Label: Atopic dermatitis patients: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: oral vitamin D; Assigned to Arm(s): Atopic dermatitis patients: Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Atopic dermatitis patients: Placebo
D: Arm Label: 400 IU Vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol (D3) or ergocalciferol (D2) | Arm Label: 400 IU Vitamin D2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol (D3) or ergocalciferol (D2) | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol (D3) or ergocalciferol (D2); Assigned to Arm(s): 400 IU Vitamin D2, 400 IU Vitamin D3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cost Effectiveness of Building Capacity of Mid-level Practitioners in Sub-Saharan Africa for the Care and Prevention of HIV, Tuberculosis, Malaria and Related Infectious Diseases
Brief Summary: This evaluation aim is to investigate a cost-effective way to build capacity for the care and prevention of infectious diseases among mid-level practitioners (MLP) in sub-Saharan Africa. Classroom based training continues to be the dominant form of training, despite evidence that suggests that on-site support (OSS) is more beneficial. Definitive evidence that on-site support is the most effective way to deliver the required outputs and related outcomes is still lacking. IDCAP will provide two interventions that integrate training in TB, HIV/AIDS and malaria as well as other infectious diseases, and the effects will be studied: 1) Integrated Management of Infectious Disease (IMID) training program for individual MLP, and 2) On-site support (OSS) for team of health professionals. This study employs a mixed design with pre/post and cluster randomized trial components. Interventions are at the level of the individual participant for IMID and at the level of the site (health facility) for OSS. All participants attend a 3-week course, followed by two 1-week booster courses over a six month period. After the 3-week course, a randomized arm of half the sampled facilities also received OSS every month for 9 months and bi-monthly for 6 additional months.


Options:
A: Arm Label: OSS Phase 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Arm Label: OSS Phase 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training and Supervision, Behavioral: Integrated Management of Infectious Disease (IMID) | Intervention Type: BEHAVIORAL; Name: Training and supervision; Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Training and Supervision; Assigned to Arm(s): OSS Phase 2 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 1 | Intervention Type: BEHAVIORAL; Name: Integrated Management of Infectious Disease (IMID); Assigned to Arm(s): OSS Phase 2
B: Intervention Type: BEHAVIORAL; Name: knowledge-adaptive Web-based instruction; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention
D: Arm Label: E-learning program; Type: N/A; Interventions: Other: E-learning program | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: E-learning program; Assigned to Arm(s): E-learning program

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at Increased Risk of Recurrence
Brief Summary: REMICADE (infliximab) is a drug used to treat active Crohn's disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection. This study will compare the effects (both good and bad) of REMICADE (infliximab) to those of placebo. Placebo looks like the drug being studied but has no active ingredients.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: infliximab | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: infliximab; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: PRECISION dosing; Type: EXPERIMENTAL; Interventions: Drug: PRECISION dosing Infliximab | Arm Label: Conventional dosing of Infliximab; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: PRECISION dosing Infliximab; Assigned to Arm(s): PRECISION dosing
C: Arm Label: Infliximab; Type: EXPERIMENTAL; Interventions: Biological: Infliximab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Infliximab; Assigned to Arm(s): Infliximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Usual Care practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Algorithm; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Algorithm for Crohn's Disease | Intervention Type: OTHER; Name: Treatment Algorithm for Crohn's Disease; Assigned to Arm(s): Treatment Algorithm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at Increased Risk of Recurrence
Brief Summary: REMICADE (infliximab) is a drug used to treat active Crohn's disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection. This study will compare the effects (both good and bad) of REMICADE (infliximab) to those of placebo. Placebo looks like the drug being studied but has no active ingredients.


Options:
A: Arm Label: Active arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: endoscopy | Arm Label: Standard care arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: endoscopy; Assigned to Arm(s): Active arm
B: Arm Label: Systematic azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Arm Label: Endoscopy-driven azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine in case of endoscopic recurrence, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Systematic azathioprine group | Intervention Type: DRUG; Name: Azathioprine in case of endoscopic recurrence; Assigned to Arm(s): Endoscopy-driven azathioprine group | Intervention Type: PROCEDURE; Name: Ileocolonoscopy; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group | Intervention Type: PROCEDURE; Name: Small bowel follow trough; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group
C: Arm Label: Infliximab; Type: EXPERIMENTAL; Interventions: Biological: Infliximab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Infliximab; Assigned to Arm(s): Infliximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Metronidazole + Azathioprine.; Type: EXPERIMENTAL; Interventions: Drug: Metronidazole, Drug: Azathioprine | Arm Label: Metronidazole + Adalimumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole, Drug: Adalimumab | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole + Azathioprine. | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole + Adalimumab | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Metronidazole + Azathioprine. | Intervention Type: DRUG; Name: Adalimumab; Assigned to Arm(s): Metronidazole + Adalimumab

Answer: C